Biological Rationale and Clinical Evidence of Carbon Ion Radiation Therapy for Adenoid Cystic Carcinoma: A Narrative Review

Adenoid cystic carcinoma (ACC) is a rare, basaloid, epithelial tumor, arising mostly from salivary glands. Radiation therapy can be employed as a single modality for unresectable tumors, in an adjuvant setting after uncomplete resection, in case of high-risk pathological features, or for recurrent t...

Full description

Bibliographic Details
Main Authors: Pierre Loap, Barbara Vischioni, Maria Bonora, Rossana Ingargiola, Sara Ronchi, Viviana Vitolo, Amelia Barcellini, Lucia Goanta, Ludovic De Marzi, Remi Dendale, Roberto Pacelli, Laura Locati, Valentin Calugaru, Hamid Mammar, Stefano Cavalieri, Youlia Kirova, Ester Orlandi
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-11-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.789079/full
_version_ 1828975468898942976
author Pierre Loap
Pierre Loap
Pierre Loap
Barbara Vischioni
Maria Bonora
Rossana Ingargiola
Sara Ronchi
Viviana Vitolo
Amelia Barcellini
Lucia Goanta
Ludovic De Marzi
Ludovic De Marzi
Ludovic De Marzi
Remi Dendale
Remi Dendale
Roberto Pacelli
Laura Locati
Laura Locati
Valentin Calugaru
Valentin Calugaru
Hamid Mammar
Hamid Mammar
Stefano Cavalieri
Stefano Cavalieri
Youlia Kirova
Youlia Kirova
Ester Orlandi
author_facet Pierre Loap
Pierre Loap
Pierre Loap
Barbara Vischioni
Maria Bonora
Rossana Ingargiola
Sara Ronchi
Viviana Vitolo
Amelia Barcellini
Lucia Goanta
Ludovic De Marzi
Ludovic De Marzi
Ludovic De Marzi
Remi Dendale
Remi Dendale
Roberto Pacelli
Laura Locati
Laura Locati
Valentin Calugaru
Valentin Calugaru
Hamid Mammar
Hamid Mammar
Stefano Cavalieri
Stefano Cavalieri
Youlia Kirova
Youlia Kirova
Ester Orlandi
author_sort Pierre Loap
collection DOAJ
description Adenoid cystic carcinoma (ACC) is a rare, basaloid, epithelial tumor, arising mostly from salivary glands. Radiation therapy can be employed as a single modality for unresectable tumors, in an adjuvant setting after uncomplete resection, in case of high-risk pathological features, or for recurrent tumors. Due to ACC intrinsic radioresistance, high linear energy transfer (LET) radiotherapy techniques have been evaluated for ACC irradiation: while fast neutron therapy has now been abandoned due to toxicity concerns, charged particle beams such as protons and carbon ions are at present the beams used for hadron therapy. Carbon ion radiation therapy (CIRT) is currently increasingly used for ACC irradiation. The aim of this review is to describe the immunological, molecular and clinicopathological bases that support ACC treatment with CIRT, as well as to expose the current clinical evidence that reveal the advantages of using CIRT for treating ACC.
first_indexed 2024-12-14T14:20:47Z
format Article
id doaj.art-6abf9a0c59344ab7b3ad937177ddf0f3
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-14T14:20:47Z
publishDate 2021-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-6abf9a0c59344ab7b3ad937177ddf0f32022-12-21T22:58:04ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-11-011110.3389/fonc.2021.789079789079Biological Rationale and Clinical Evidence of Carbon Ion Radiation Therapy for Adenoid Cystic Carcinoma: A Narrative ReviewPierre Loap0Pierre Loap1Pierre Loap2Barbara Vischioni3Maria Bonora4Rossana Ingargiola5Sara Ronchi6Viviana Vitolo7Amelia Barcellini8Lucia Goanta9Ludovic De Marzi10Ludovic De Marzi11Ludovic De Marzi12Remi Dendale13Remi Dendale14Roberto Pacelli15Laura Locati16Laura Locati17Valentin Calugaru18Valentin Calugaru19Hamid Mammar20Hamid Mammar21Stefano Cavalieri22Stefano Cavalieri23Youlia Kirova24Youlia Kirova25Ester Orlandi26Radiation Oncology Unit, Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, ItalyDepartment of Radiation Oncology, Institut Curie, Paris, FranceProton Therapy Center, Institut Curie, Orsay, FranceRadiation Oncology Unit, Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, ItalyRadiation Oncology Unit, Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, ItalyRadiation Oncology Unit, Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, ItalyRadiation Oncology Unit, Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, ItalyRadiation Oncology Unit, Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, ItalyRadiation Oncology Unit, Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, ItalyDepartment of Advanced Biomedical Sciences, University of Naples “Federico II”, Napoli, ItalyDepartment of Radiation Oncology, Institut Curie, Paris, FranceProton Therapy Center, Institut Curie, Orsay, FranceInstitut Curie, PSL Research University, University Paris Saclay, INSERM LITO, Orsay, FranceDepartment of Radiation Oncology, Institut Curie, Paris, FranceProton Therapy Center, Institut Curie, Orsay, FranceDepartment of Advanced Biomedical Sciences, University of Naples “Federico II”, Napoli, ItalyMedical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, ItalyDepartment of Oncology and Hemato-Oncology, University of Milan, Milan, ItalyDepartment of Radiation Oncology, Institut Curie, Paris, FranceProton Therapy Center, Institut Curie, Orsay, FranceDepartment of Radiation Oncology, Institut Curie, Paris, FranceProton Therapy Center, Institut Curie, Orsay, FranceMedical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, ItalyDepartment of Oncology and Hemato-Oncology, University of Milan, Milan, ItalyDepartment of Radiation Oncology, Institut Curie, Paris, FranceProton Therapy Center, Institut Curie, Orsay, FranceRadiation Oncology Unit, Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, ItalyAdenoid cystic carcinoma (ACC) is a rare, basaloid, epithelial tumor, arising mostly from salivary glands. Radiation therapy can be employed as a single modality for unresectable tumors, in an adjuvant setting after uncomplete resection, in case of high-risk pathological features, or for recurrent tumors. Due to ACC intrinsic radioresistance, high linear energy transfer (LET) radiotherapy techniques have been evaluated for ACC irradiation: while fast neutron therapy has now been abandoned due to toxicity concerns, charged particle beams such as protons and carbon ions are at present the beams used for hadron therapy. Carbon ion radiation therapy (CIRT) is currently increasingly used for ACC irradiation. The aim of this review is to describe the immunological, molecular and clinicopathological bases that support ACC treatment with CIRT, as well as to expose the current clinical evidence that reveal the advantages of using CIRT for treating ACC.https://www.frontiersin.org/articles/10.3389/fonc.2021.789079/fulladenoid cyst carcinomahadrontherapycarbon ion radiotherapy (CIRT)tumor immunologyradioresistance
spellingShingle Pierre Loap
Pierre Loap
Pierre Loap
Barbara Vischioni
Maria Bonora
Rossana Ingargiola
Sara Ronchi
Viviana Vitolo
Amelia Barcellini
Lucia Goanta
Ludovic De Marzi
Ludovic De Marzi
Ludovic De Marzi
Remi Dendale
Remi Dendale
Roberto Pacelli
Laura Locati
Laura Locati
Valentin Calugaru
Valentin Calugaru
Hamid Mammar
Hamid Mammar
Stefano Cavalieri
Stefano Cavalieri
Youlia Kirova
Youlia Kirova
Ester Orlandi
Biological Rationale and Clinical Evidence of Carbon Ion Radiation Therapy for Adenoid Cystic Carcinoma: A Narrative Review
Frontiers in Oncology
adenoid cyst carcinoma
hadrontherapy
carbon ion radiotherapy (CIRT)
tumor immunology
radioresistance
title Biological Rationale and Clinical Evidence of Carbon Ion Radiation Therapy for Adenoid Cystic Carcinoma: A Narrative Review
title_full Biological Rationale and Clinical Evidence of Carbon Ion Radiation Therapy for Adenoid Cystic Carcinoma: A Narrative Review
title_fullStr Biological Rationale and Clinical Evidence of Carbon Ion Radiation Therapy for Adenoid Cystic Carcinoma: A Narrative Review
title_full_unstemmed Biological Rationale and Clinical Evidence of Carbon Ion Radiation Therapy for Adenoid Cystic Carcinoma: A Narrative Review
title_short Biological Rationale and Clinical Evidence of Carbon Ion Radiation Therapy for Adenoid Cystic Carcinoma: A Narrative Review
title_sort biological rationale and clinical evidence of carbon ion radiation therapy for adenoid cystic carcinoma a narrative review
topic adenoid cyst carcinoma
hadrontherapy
carbon ion radiotherapy (CIRT)
tumor immunology
radioresistance
url https://www.frontiersin.org/articles/10.3389/fonc.2021.789079/full
work_keys_str_mv AT pierreloap biologicalrationaleandclinicalevidenceofcarbonionradiationtherapyforadenoidcysticcarcinomaanarrativereview
AT pierreloap biologicalrationaleandclinicalevidenceofcarbonionradiationtherapyforadenoidcysticcarcinomaanarrativereview
AT pierreloap biologicalrationaleandclinicalevidenceofcarbonionradiationtherapyforadenoidcysticcarcinomaanarrativereview
AT barbaravischioni biologicalrationaleandclinicalevidenceofcarbonionradiationtherapyforadenoidcysticcarcinomaanarrativereview
AT mariabonora biologicalrationaleandclinicalevidenceofcarbonionradiationtherapyforadenoidcysticcarcinomaanarrativereview
AT rossanaingargiola biologicalrationaleandclinicalevidenceofcarbonionradiationtherapyforadenoidcysticcarcinomaanarrativereview
AT sararonchi biologicalrationaleandclinicalevidenceofcarbonionradiationtherapyforadenoidcysticcarcinomaanarrativereview
AT vivianavitolo biologicalrationaleandclinicalevidenceofcarbonionradiationtherapyforadenoidcysticcarcinomaanarrativereview
AT ameliabarcellini biologicalrationaleandclinicalevidenceofcarbonionradiationtherapyforadenoidcysticcarcinomaanarrativereview
AT luciagoanta biologicalrationaleandclinicalevidenceofcarbonionradiationtherapyforadenoidcysticcarcinomaanarrativereview
AT ludovicdemarzi biologicalrationaleandclinicalevidenceofcarbonionradiationtherapyforadenoidcysticcarcinomaanarrativereview
AT ludovicdemarzi biologicalrationaleandclinicalevidenceofcarbonionradiationtherapyforadenoidcysticcarcinomaanarrativereview
AT ludovicdemarzi biologicalrationaleandclinicalevidenceofcarbonionradiationtherapyforadenoidcysticcarcinomaanarrativereview
AT remidendale biologicalrationaleandclinicalevidenceofcarbonionradiationtherapyforadenoidcysticcarcinomaanarrativereview
AT remidendale biologicalrationaleandclinicalevidenceofcarbonionradiationtherapyforadenoidcysticcarcinomaanarrativereview
AT robertopacelli biologicalrationaleandclinicalevidenceofcarbonionradiationtherapyforadenoidcysticcarcinomaanarrativereview
AT lauralocati biologicalrationaleandclinicalevidenceofcarbonionradiationtherapyforadenoidcysticcarcinomaanarrativereview
AT lauralocati biologicalrationaleandclinicalevidenceofcarbonionradiationtherapyforadenoidcysticcarcinomaanarrativereview
AT valentincalugaru biologicalrationaleandclinicalevidenceofcarbonionradiationtherapyforadenoidcysticcarcinomaanarrativereview
AT valentincalugaru biologicalrationaleandclinicalevidenceofcarbonionradiationtherapyforadenoidcysticcarcinomaanarrativereview
AT hamidmammar biologicalrationaleandclinicalevidenceofcarbonionradiationtherapyforadenoidcysticcarcinomaanarrativereview
AT hamidmammar biologicalrationaleandclinicalevidenceofcarbonionradiationtherapyforadenoidcysticcarcinomaanarrativereview
AT stefanocavalieri biologicalrationaleandclinicalevidenceofcarbonionradiationtherapyforadenoidcysticcarcinomaanarrativereview
AT stefanocavalieri biologicalrationaleandclinicalevidenceofcarbonionradiationtherapyforadenoidcysticcarcinomaanarrativereview
AT youliakirova biologicalrationaleandclinicalevidenceofcarbonionradiationtherapyforadenoidcysticcarcinomaanarrativereview
AT youliakirova biologicalrationaleandclinicalevidenceofcarbonionradiationtherapyforadenoidcysticcarcinomaanarrativereview
AT esterorlandi biologicalrationaleandclinicalevidenceofcarbonionradiationtherapyforadenoidcysticcarcinomaanarrativereview